Research

Mixed

Metabolic surgery reduces the 10-year risk of major adverse cardiovascular events (all-cause mortality, coronary artery events, heart failure, and nephropathy) in patients with type 2 diabetes and obesity compared to usual care, as quantified by the Individualized Diabetes Complications (IDC) Risk Scores.

If you have type 2 diabetes and obesity, ask your doctor about using a risk calculator (like the IDC Risk Scores) to compare your 10-year risk of heart failure, kidney disease, and death with current medications versus metabolic surgery. The data suggests surgery may significantly lower these risks for many patients, helping you make an informed decision based on your specific health profile.

GoodSupportsHIGH confidence
The IDC Risk Scores can provide personalized evidence-based risk information for patients with type 2 diabetes and obesity about future cardiovascular outcomes and mortality with and without metabolic surgery based on their current status of obesity, diabetes, and related cardiometabolic conditions.
Ali Aminian et al. · Diabetes Care · 2020

Why this rating

Large retrospective cohort (n=13,722) with propensity matching and internal validation, though not a randomized controlled trial.

Source

Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach

Ali Aminian et al. · Diabetes Care · 2020

DOI 10.2337/dc19-2057

cohort · n=13722Cited 95×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →